Literature DB >> 27848008

[Preoperative therapy switch before glaucoma filtration surgery : Influence of the systemic antiglaucomatous and local antiphlogistic therapy on the intraocular pressure].

I Oberacher-Velten1, F Zeman2, F Lehmann3, T Barth3, P Peters3, H Helbig3, R Greslechner3.   

Abstract

BACKGROUND: The preoperative switch from local to systemic antiglaucomatous therapy and the additional application of local antiphlogistic drugs represents an important component of perioperative wound healing modulation within the framework of glaucoma filtration surgery.
OBJECTIVE: The aim of the present study was to compare the intraocular pressure (IOP) under a maximum local and oral antiglaucomatous therapy with or without additional application of local steroids.
METHODS: A retrospective clinical analysis of 121 consecutive patients who underwent primary trabeculectomy for open-angle glaucoma in 2013 and who attended the outpatient clinic at least 3 weeks before surgery was carried out. The patients were set on preoperative therapy as follows: continuation of the maximum local antiglaucomatous therapy (with or without local dexamethasone 1 mg/ml 3 times daily) or administration of 750 mg acetazolamide orally per day (with or without local steroids).
RESULTS: The switch to oral antiglaucomatous therapy led to a mean IOP rise of 3.14 mm Hg which was short of statistical significance (p = 0.052). The additional administration of local steroids did not significantly influence the IOP (p = 0.218). Some patients with oral acetazolamide therapy and local steroid application showed large increases in IOP up to 30 mm Hg.
CONCLUSION: The mean IOP rise of 3.14 mm Hg 3 weeks after replacement of antiglaucomatous eye drops by acetazolamide was short of missing statistical significance and seems to be clinically negligible for this relatively short period. The advantages of a lower postoperative fibrotic activity have to be weighed up against this change in IOP. Surprisingly, the effect of administration of local steroids for 3 weeks was minor compared to the effect of the switch from local to oral antiglaucomatous medication. Individual major IOP increases under the preoperative therapy change should be taken into consideration.

Entities:  

Keywords:  Acetazolamide; Local steroids; Oral antiglaucomatous therapy; Preoperative therapy; Trabeculectomy

Mesh:

Substances:

Year:  2017        PMID: 27848008     DOI: 10.1007/s00347-016-0396-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  24 in total

1.  Comparison of in vitro potency of corticosteroids with ability to raise intraocular pressure.

Authors:  H L Cantrill; P F Palmberg; H A Zink; S R Waltman; S M Podos; B Becker
Journal:  Am J Ophthalmol       Date:  1975-06       Impact factor: 5.258

2.  Short-term, high-dose systemic steroids and intraocular pressure.

Authors:  Marcelo Gehlen; Ana Paula Canto; Thelma L Skare; Francisco Araújo; Osvaldo Haider
Journal:  Can J Ophthalmol       Date:  2009-08       Impact factor: 1.882

3.  Topical antiglaucomatous therapy: adverse effects on the conjunctiva and implications for filtration surgery.

Authors:  D Broadway; R Hitchings; I Grierson
Journal:  J Glaucoma       Date:  1995-04       Impact factor: 2.503

Review 4.  Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglaucomatous drugs?

Authors:  C Baudouin
Journal:  Int J Clin Pharmacol Res       Date:  1996

5.  Intraocular pressure response to topical corticosteroids.

Authors:  M F Armaly; B Becker
Journal:  Fed Proc       Date:  1965 Nov-Dec

6.  Acute effects of dexamethasone on intraocular pressure in glaucoma.

Authors:  R N Weinreb; J R Polansky; S G Kramer; J D Baxter
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-02       Impact factor: 4.799

7.  Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.

Authors:  Jost B Jonas; Robert F Degenring; Ingrid Kreissig; Imren Akkoyun; Bernd A Kamppeter
Journal:  Ophthalmology       Date:  2005-04       Impact factor: 12.079

8.  Early conjunctival changes following treatment with metipranolol and preservatives are not reversible with dexamethasone.

Authors:  H Mietz; U Schlötzer-Schrehardt; J H Lemke; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-07       Impact factor: 3.117

9.  In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.

Authors:  Christophe Baudouin; Luisa Riancho; Jean-Michel Warnet; Françoise Brignole
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

10.  Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system.

Authors:  Hong Liang; Aude Pauly; Luisa Riancho; Christophe Baudouin; Françoise Brignole-Baudouin
Journal:  Br J Ophthalmol       Date:  2011-03-22       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.